News|Videos|December 11, 2024
Value-based payment models: Problematic performance measures
Author(s)Richard Payerchin
Key Takeaways
- Measuring patient outcomes in value-based care is complex and often inadequately performed, posing significant challenges.
- Primary care practitioners show reluctance to join value-based payment models due to difficulties in performance measurement.
A physician researcher discusses why primary care physicians do not participate in value-based payment models.
Advertisement
he best way to measure patient outcomes? “Measuring that is very tricky to do, and we don't do it that well,” said Ann S. O’Malley, MD, MPH, a researcher for Mathematica. Here she continues explaining some of the
Advertisement
Related to this article
CMS chief says outcomes-based pay can help patients while finally ending physicians' box-checking frustration.
RFK Jr. appoints members to fill a panel that has not met in more than a year, but is influential on primary care.
Median work RVUs rose no more than 2.8% in any group, while nearly 65% of surveyed organizations plan to add physicians in the coming year.
Kidney care advocates praise new appointees; advocacy group notes the task force creates financial effects on patients.
A primary-care voucher model would pay practices upfront for predictable care and leave insurance to cover catastrophic risk, cutting administrative burden and giving physicians time back with patients.
A new Physicians Foundation survey finds 36% of physicians say they or a colleague feared seeking mental health care because of questions on licensing, credentialing or insurance applications.
Current quality programs measure organizations and claims after the fact, but the next generation of measurement focuses on the everyday clinical decisions that drive unnecessary spending.
Advertisement
Advertisement
Trending on Medical Economics
1
Most Americans say a pension beats a 401(k), survey finds
2
Physician pay rose across every specialty group in 2026, SullivanCotter survey finds
3
Pharmacist-led medication review cuts inappropriate prescribing in older adults with cancer
4
Why AI scribe notes can put your G2211 reimbursement at risk
5